Synopsys (SNPS)
(Delayed Data from NSDQ)
$561.55 USD
-12.04 (-2.10%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $561.71 +0.16 (0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$561.55 USD
-12.04 (-2.10%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $561.71 +0.16 (0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Zacks News
Synopsys (SNPS), Samsung Tie Up for Voltage-Timing Signoff Solution
by Zacks Equity Research
In collaboration with Samsung Foundry and Ansys, Synopsys (SNPS) develops an advanced voltage-timing signoff solution accelerating energy-efficient designs with optimal power, performance and area.
Here's How Much You'd Have If You Invested $1000 in Synopsys a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Synopsys (SNPS) Crossed Above the 200-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Synopsys (SNPS) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
Why Is Synopsys (SNPS) Up 3.7% Since Last Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synopsys (SNPS) CODE V & LightTools Upgraded for Interoperability
by Zacks Equity Research
Synopsys (SNPS) to offer new and enhanced interoperability feature between CODE V and LightTools to help optical designers develop systems saving time and unnecessary effort.
Here is Why Growth Investors Should Buy Synopsys (SNPS) Now
by Zacks Equity Research
Synopsys (SNPS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Synopsys (SNPS) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Synopsys' (SNPS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Synopsys (SNPS) Q1 results reflect benefits from solid demand for its products amid rapid adoption of Big Data, faster computation and Machine Learning.
Synopsys (SNPS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 1.27% and 0.56%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 Technical Analysis, The Super Bowl Indicator & What's Ahead
by Daniel Laboe
We are now in a buy zone between the S&P 500???s correction threshold and its 200-day MA
Innovation-Fueled Equities Get Some Valentine's Day Love as Rates Finally Take Flight
by Daniel Laboe
The sizzling hot January CPI report, hawkish statements from St. Louis Fed President James Bullard, and escalating tensions at Ukraine's border are driving the most recent fear-fueled market volatility
Synopsys (SNPS) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Synopsys' (SNPS) Q1 results are likely to have witnessed strong demand for its advanced solutions on the increased adoption of AI, 5G, the Internet of things and high-performance cloud computing.
Synopsys (SNPS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Synopsys (SNPS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Buy The Chip Dip!
by Daniel Laboe
The semiconductor sector is ripe with buying opportunities after the recent market dip and this earnings season should generate some robust springboard price-action for well-positioned chip stocks.
Aspen Technology (AZPN) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Aspen Technology (AZPN) delivered earnings and revenue surprises of -16.08% and 8.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
VMW vs. SNPS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VMW vs. SNPS: Which Stock Is the Better Value Option?
Why Is Synopsys (SNPS) Up 6.1% Since Last Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synopsys' (SNPS) OptoCompiler Chosen by Juniper Networks
by Zacks Equity Research
Synopsys' (SNPS) OptoCompiler platform selected by a leading provider of networking solutions and communication devices, Juniper Networks, to develop photonic-enabled chips.
Synopsys (SNPS) to Buy Back Stock Worth $200M Under ASR Pact
by Zacks Equity Research
Synopsys (SNPS) is likely to boost shareholder wealth as it enters an accelerated share repurchase program with HSBC Bank USA, National Association to buy back its common stock worth $200 million.
Synopsys' (SNPS) Buyback Plan to Boost Shareholders' Wealth
by Zacks Equity Research
Synopsys' (SNPS) latest $1 billion share repurchase authorization indicates its commitment toward delivering long-term shareholder value and reflects its confidence in generating sufficient cash flows.
Synopsys' (SNPS) Q4 Earnings Beat Estimates, Revenues Meet
by Zacks Equity Research
Synopsys' (SNPS) fourth-quarter fiscal 2021 results reflect the benefits from increasing demand for its products amid the rapid adoption of Big Data, faster computation and Machine Learning.
Synopsys (SNPS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 2.25% and 0.08%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
VMW vs. SNPS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VMW vs. SNPS: Which Stock Is the Better Value Option?
Stratasys (SSYS) Launches Digital Anatomy Creator Software
by Zacks Equity Research
Stratasys (SSYS) enhances personalized healthcare capabilities with the addition of Digital Anatomy Creator software to its medical modeling offerings.